ESMO Targeted Anticancer Therapies (TAT) Asia Congress 2026 will be held from 12th - 14th June 2026 in Hong Kong. This is a premier scientific event dedicated to the rapid evolution of precision oncology. It focuses on the development of novel anti-cancer agents, bringing together leading researchers, clinicians, and industry pioneers to discuss the latest breakthroughs in drug discovery, early-phase clinical trials, and translational research. It provides a vital platform for exploring immunotherapy, antibody-drug conjugates, and targeted inhibitors. It serves as a unique forum for fostering international collaboration and accelerating the delivery of innovative, life-saving therapies to cancer patients across Asia and beyond.